Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Feeding Intolerance and NEC in Preterm Infants
NCT04304807Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in feeding intolerance, necrotizing enterocolitis (NEC), sponsored by Ain Shams University. Started Dec 2018; status: completed.
02
Drugs
melatonin
03
Conditions
feeding intolerancenecrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT04304807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04304807.